COVID-19 pandemic waves and mortality among patients on kidney replacement therapy

Priya Vart; Kitty J Jager; Miha Arnol; Raphaël Duivenvoorden; Casper F M Franssen; Marc Groeneveld; Marc H Hemmelder; Fanny Lepeytre; Thomas Malfait; Karsten Midtvedt; Sandip Mitra; Carme Facundo; Marlies Noordzij; Carlos C Reina; Seda Safak; Nestor Toapanta; Luuk B Hilbrands; Ron T Gansevoort

doi:10.1016/j.ekir.2022.06.007

COVID-19 pandemic waves and mortality among patients on kidney replacement therapy

Priya Vart^*, Kitty J Jager, Miha Arnol, Raphaël Duivenvoorden, Casper F M Franssen, Marc Groeneveld, Marc H Hemmelder, Fanny Lepeytre, Thomas Malfait, Karsten Midtvedt, Sandip Mitra, Carme Facundo, Marlies Noordzij, Carlos C Reina, Seda Safak, Nestor Toapanta, Luuk B Hilbrands, Ron T Gansevoort

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	2091-2096
Number of pages	6
Journal	Kidney International Reports
Volume	7
Issue number	9
Early online date	20 Jun 2022
DOIs	https://doi.org/10.1016/j.ekir.2022.06.007
Publication status	Published - Sept 2022

Access to Document

10.1016/j.ekir.2022.06.007Licence: Other

Cite this

Vart, P., Jager, K. J., Arnol, M., Duivenvoorden, R., Franssen, C. F. M., Groeneveld, M., Hemmelder, M. H., Lepeytre, F., Malfait, T., Midtvedt, K., Mitra, S., Facundo, C., Noordzij, M., Reina, C. C., Safak, S., Toapanta, N., Hilbrands, L. B., & Gansevoort, R. T. (2022). COVID-19 pandemic waves and mortality among patients on kidney replacement therapy. Kidney International Reports, 7(9), 2091-2096. https://doi.org/10.1016/j.ekir.2022.06.007

@article{fb3e6e5a4b3c4c58a983e15198a552b2,

title = "COVID-19 pandemic waves and mortality among patients on kidney replacement therapy",

author = "Priya Vart and Jager, {Kitty J} and Miha Arnol and Rapha{\"e}l Duivenvoorden and Franssen, {Casper F M} and Marc Groeneveld and Hemmelder, {Marc H} and Fanny Lepeytre and Thomas Malfait and Karsten Midtvedt and Sandip Mitra and Carme Facundo and Marlies Noordzij and Reina, {Carlos C} and Seda Safak and Nestor Toapanta and Hilbrands, {Luuk B} and Gansevoort, {Ron T}",

note = "Funding Information: This work was supported with unrestricted grants from European Renal Association (ERA), Nierstichting (Dutch Kidney Foundation), Baxter, and Sandoz unrestricted research grants. We thank all people who entered information in the ERACODA database for their participation, and especially all health care workers who have taken care of the included COVID-19 patients. The funding organizations had no role in the design of the study, data collection, data analysis, interpretation of results, or in writing of the manuscript. All authors contributed to data collection, study design, data analysis, interpretation, and drafting of this paper. The ERACODA Collaboration is an initiative to study prognosis and risk factors for mortality due to COVID-19 in patients with a kidney transplant or on dialysis that is endorsed by the ERA. ERACODA is an acronym for the ERA COVID-19 Database. The organizational structure contains a working group, assisted by a management team and an advisory board. The ERACODA Working Group members are C.F.M. Franssen, R.T. Gansevoort (Coordinator), M.H. Hemmelder, L.B. Hilbrands, and K.J. Jager; the ERACODA Management Team members are R. Duivenvoorden, M. Noordzij, and P. Vart; the ERACODA Advisory Board members are D. Abramowicz, C. Basile, A. Covic, M. Crespo, Z.A. Massy, S. Mitra, E. Petridou, J.E. Sanchez, and C. White. RTG, LBH, KJJ, and PV were involved in the design of the study. PV wrote the first draft of the manuscript and performed the data analyses. All authors reviewed the manuscript drafts for important intellectual content, provided approval of the final version for submission and take responsibility for the accuracy and integrity of the data.",

year = "2022",

month = sep,

doi = "10.1016/j.ekir.2022.06.007",

language = "English",

volume = "7",

pages = "2091--2096",

journal = "Kidney International Reports",

issn = "2468-0249",

publisher = "Elsevier Inc.",

number = "9",

}

Vart, P, Jager, KJ, Arnol, M, Duivenvoorden, R, Franssen, CFM, Groeneveld, M, Hemmelder, MH, Lepeytre, F, Malfait, T, Midtvedt, K, Mitra, S, Facundo, C, Noordzij, M, Reina, CC, Safak, S, Toapanta, N, Hilbrands, LB & Gansevoort, RT 2022, 'COVID-19 pandemic waves and mortality among patients on kidney replacement therapy', Kidney International Reports, vol. 7, no. 9, pp. 2091-2096. https://doi.org/10.1016/j.ekir.2022.06.007

TY - JOUR

T1 - COVID-19 pandemic waves and mortality among patients on kidney replacement therapy

AU - Vart, Priya

AU - Jager, Kitty J

AU - Arnol, Miha

AU - Duivenvoorden, Raphaël

AU - Franssen, Casper F M

AU - Groeneveld, Marc

AU - Hemmelder, Marc H

AU - Lepeytre, Fanny

AU - Malfait, Thomas

AU - Midtvedt, Karsten

AU - Mitra, Sandip

AU - Facundo, Carme

AU - Noordzij, Marlies

AU - Reina, Carlos C

AU - Safak, Seda

AU - Toapanta, Nestor

AU - Hilbrands, Luuk B

AU - Gansevoort, Ron T

N1 - Funding Information: This work was supported with unrestricted grants from European Renal Association (ERA), Nierstichting (Dutch Kidney Foundation), Baxter, and Sandoz unrestricted research grants. We thank all people who entered information in the ERACODA database for their participation, and especially all health care workers who have taken care of the included COVID-19 patients. The funding organizations had no role in the design of the study, data collection, data analysis, interpretation of results, or in writing of the manuscript. All authors contributed to data collection, study design, data analysis, interpretation, and drafting of this paper. The ERACODA Collaboration is an initiative to study prognosis and risk factors for mortality due to COVID-19 in patients with a kidney transplant or on dialysis that is endorsed by the ERA. ERACODA is an acronym for the ERA COVID-19 Database. The organizational structure contains a working group, assisted by a management team and an advisory board. The ERACODA Working Group members are C.F.M. Franssen, R.T. Gansevoort (Coordinator), M.H. Hemmelder, L.B. Hilbrands, and K.J. Jager; the ERACODA Management Team members are R. Duivenvoorden, M. Noordzij, and P. Vart; the ERACODA Advisory Board members are D. Abramowicz, C. Basile, A. Covic, M. Crespo, Z.A. Massy, S. Mitra, E. Petridou, J.E. Sanchez, and C. White. RTG, LBH, KJJ, and PV were involved in the design of the study. PV wrote the first draft of the manuscript and performed the data analyses. All authors reviewed the manuscript drafts for important intellectual content, provided approval of the final version for submission and take responsibility for the accuracy and integrity of the data.

PY - 2022/9

Y1 - 2022/9

U2 - 10.1016/j.ekir.2022.06.007

DO - 10.1016/j.ekir.2022.06.007

M3 - Article

C2 - 35757188

SN - 2468-0249

VL - 7

SP - 2091

EP - 2096

JO - Kidney International Reports

JF - Kidney International Reports

IS - 9

ER -